Talk:Sodium-glucose transport proteins

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Untitled

1 Aug 2014- Empagliflozin was approved (Jardiance) by the FDA for use in DMT2.

http://us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2014/08-01-14-fda-approves-jardiance-empagliflozin-tablets-reduce-blood-sugar-levels-adults-type-2-diabetes.html — Preceding unsigned comment added by 162.134.56.6 (talk) 17:52, 5 November 2014 (UTC)[reply]

Clarification needed: sodium depletion or rise in potassium?

In "Function" section I read:

sodium can deplete, so Sodium–hydrogen antiporter gets sodium into the cell to begin with.

but SGLT imports in the cell glucose and sodium, thus I see no reason for sodium depletion.

On the other hand, it is stated that Na⁺/K⁺ ATPase exports sodium and imports potassium, thus I think the limiting factor should be rise in potassium concentration.

Someone with sufficient knowledge of this matter can clarify? Fornaeffe (talk) 16:00, 14 October 2024 (UTC)[reply]

I found this section hard to follow, so I rewrote it. Hopefully it is now clearer and more accurate. Also this section is about mechanism, not function, so I renamed it. Boghog (talk) 06:20, 15 October 2024 (UTC)[reply]